Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Tatyana Nekhaeva"'
Autor:
Diana Alaverdian, Alexandr N. Chernov, Irina Baldueva, Tatyana Nekhaeva, Elvira S. Galimova, O. V. Shamova
Publikováno v:
Problems in oncology. 67:20-28
In review discusses the phenomenon of drug resistance of GB in the context of the expression of ABC family transporter proteins and the processes of proliferation, angiogenesis, recurrence and death. The emphasis is on the identifying for molecular t
Publikováno v:
Problems in oncology. 66:353-363
Selection of tolerated and toxic doses, schemes of therapy for new anticancer drugs, assessment of its toxicity, pharmacokinetics, metabolism, study of the mechanism of action and tumor sensitivity are carried out using models of human tumors in mice
Publikováno v:
Problems in oncology. 65:798-806
The progress in drug treatment of sarcomas is incredibly slow: primary, it is hindered by often developing resistance of tumors to standard chemotherapy with drugs in the maximum tolerated dosages. The clonal evolution of the tumor mass generates a h
Publikováno v:
Problems in oncology. 65:629-637
A tumor is a multicomponent, spatially difficult organi-zated system, which is characterized by individual characteristics for each patient. In vitro cell model creating that is close in structure and properties to the natural tumor system will promo
Autor:
I. Sinai, Yelena Antonova, Irina Baldueva, L. Wayn, A. P. Baranov, Tatyana Nekhaeva, A. Khambikova, Aleksandr Solovev, A. Zamir
Publikováno v:
Problems in oncology. 65:744-748
This article represents intermediate results of the research of the international project on the direction of complex diagnostics of skin melanoma. A preliminary screening of patients was carried out, which included the analysis of molecular markers
Autor:
Natalya Avdonkina, Nino Pipia, Tatyana Nekhaeva, Aleksey Novik, Georgiy Gafton, Natalya Yemelyanova, Anna Danilova, Irina Baldueva
Publikováno v:
Problems in oncology. 64:400-407
In tumor microenvironment the self-maintenance condition of T-regulatory lymphocytes (Treg) are created by tumor cells due to the production of vascular endothelial growth factor VEGF and chemokine CCL2. In the present work there was evaluated the qu
Autor:
Andrey V. Belashov, Mark Gelfond, Irina Baldueva, Oleg S. Vasyutinskii, A.A. Zhikhoreva, Tatyana Nekhaeva, Irina V. Semenova, Anna Danilova, Natalya Avdonkina
Publikováno v:
Advances in Microscopic Imaging II.
We present a comparative analysis of photodynamic-treatment induced changes in optical parameters of cancer cells obtained from individual patients with three solid tumor localizations. Accumulation of photosensitizer inside living cells was validate
Autor:
Andrey V. Panchenko, Sergey E. Pigarev, Ekaterina A. Gubareva, Mikhail Maydin, Vladimir N. Anisimov, Elena I. Fedoros, Tatyana Nekhaeva, Anastasia I. Kuznetsova, Galina S. Kireeva, Margarita L. Tyndyk, Anna Danilova, Irina Baldueva
Publikováno v:
Integrative Cancer Therapies
Integrative Cancer Therapies, Vol 18 (2019)
Integrative Cancer Therapies, Vol 18 (2019)
This study aimed to evaluate the effect of lignin-derived polyphenolic composition BP-C3 on the efficacy and hematological toxicity of cyclophosphamide (CPA). Male and female Swiss-H derived mice bearing benzo[a]pyrene-induced soft tissue sarcomas we
Autor:
Dmitrii Viktorovich Girdyuk, Irina Alexandrovna Baldueva, Dilorom Khamidovna Latipova, Gulfiya Midhatovna Teletaeva, Tatyana Nekhaeva, Aleksei Viktorovich Novik, Natalia Viktorovna Emelyanova, Anna Semenova, Svetlana Protsenko
Publikováno v:
Journal of Clinical Oncology. 39:2539-2539
2539 Background: The immune system has well-known relation to tumor progression. Numerous immune-related parameters exist, but only a minor part could be used as biomarkers, especially dynamic ones. We trained a progression prediction model based on
Autor:
Dilorom Khamidovna Latipova, Svetlana Protsenko, Irina Alexandrovna Baldueva, Natalya Shendaleva, Anton Zozulya, Anna Semenova, Gulfiya Midhatovna Teletaeva, Tatyana Nekhaeva, Aleksei Viktorovich Novik, Tatiana Semiglazova
Publikováno v:
Journal of Clinical Oncology. 39:e23534-e23534
e23534 Background: Immunomodulators are used in the management of patients with soft tissue sarcoma, (STS). However, the precise mechanism behind their benefits in anticancer therapy effects have yet to be determined. We assessed the impact of the im